Identification of necroptosis-related long non-coding RNAs prognostic signature and the crucial lncRNA in bladder cancer.

[1]  Aitao Nai,et al.  A novel pyroptosis-related prognostic lncRNAs signature, tumor immune microenvironment and the associated regulation axes in bladder cancer , 2022, Frontiers in Genetics.

[2]  Ye Yuan,et al.  Comprehensive analysis of autophagy related long non-coding RNAs in prognosis, immunity, and treatment of muscular invasive bladder cancer , 2022, Scientific Reports.

[3]  Li Canxuan,et al.  Comprehensive Characterization of Necroptosis-Related lncRNAs in Bladder Cancer Identifies a Novel Signature for Prognosis Prediction , 2022, Disease markers.

[4]  Mehran Abbasi Shirsavar,et al.  Machine learning-assisted E-jet printing for manufacturing of organic flexible electronics. , 2022, Biosensors & bioelectronics.

[5]  F. Tang,et al.  Prognosis Risk Model Based on Pyroptosis-Related lncRNAs for Bladder Cancer , 2022, Disease markers.

[6]  Xin-yu Li,et al.  A Novel Model Based on Necroptosis-Related Genes for Predicting Prognosis of Patients With Prostate Adenocarcinoma , 2022, Frontiers in Bioengineering and Biotechnology.

[7]  Hui Cao,et al.  A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients , 2021, Frontiers in Cell and Developmental Biology.

[8]  Xingyu Zhou,et al.  Necroptosis-Related lncRNAs: Predicting Prognosis and the Distinction between the Cold and Hot Tumors in Gastric Cancer , 2021, Journal of oncology.

[9]  Yumeng Chai,et al.  Identification of a Nomogram from Ferroptosis-Related Long Noncoding RNAs Signature to Analyze Overall Survival in Patients with Bladder Cancer , 2021, Journal of oncology.

[10]  Jong-Ho Cha,et al.  RIPK3 activation induces TRIM28 derepression in cancer cells and enhances the anti-tumor microenvironment , 2021, Molecular Cancer.

[11]  Cai-xia Zhang,et al.  Identification of a Novel Glycolysis-Related LncRNA Signature for Predicting Overall Survival in Patients With Bladder Cancer , 2021, Frontiers in Genetics.

[12]  Jiayi Zeng,et al.  A Novel Immune-Related lncRNA-Based Model for Survival Prediction in Clear Cell Renal Cell Carcinoma , 2021, Journal of immunology research.

[13]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[14]  Shicheng Yu,et al.  A Competing Endogenous RNA Network and an 8-lncRNA Prognostic Signature Identify MYO16-AS1 as an Oncogenic lncRNA in Bladder Cancer. , 2020, DNA and cell biology.

[15]  Ching-Feng Cheng,et al.  Master Regulator Activating Transcription Factor 3 (ATF3) in Metabolic Homeostasis and Cancer , 2020, Frontiers in Endocrinology.

[16]  Chong Li,et al.  Non-coding RNA in bladder cancer. , 2020, Cancer letters.

[17]  Congcong Yan,et al.  Computational recognition of lncRNA signature of tumor-infiltrating B lymphocytes with potential implications in prognosis and immunotherapy of bladder cancer , 2020, Briefings Bioinform..

[18]  Jie-Xi Ju,et al.  MicroRNA-381-3p Functions as a Dual Suppressor of Apoptosis and Necroptosis and Promotes Proliferation of Renal Cancer Cells , 2020, Frontiers in Cell and Developmental Biology.

[19]  Tianxin Lin,et al.  circRIP2 accelerates bladder cancer progression via miR-1305/Tgf-β2/smad3 pathway , 2020, Molecular Cancer.

[20]  Jiong Wu,et al.  LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription , 2019, Molecular Cancer.

[21]  Tianjun Li,et al.  Identification of Cancer-Related Long Non-Coding RNAs Using XGBoost With High Accuracy , 2019, Front. Genet..

[22]  B. Ogretmen,et al.  Sphingolipid metabolism in cancer signalling and therapy , 2017, Nature Reviews Cancer.

[23]  K. Hoadley,et al.  Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy. , 2017, European urology.

[24]  B. Krause,et al.  Wntless promotes bladder cancer growth and acts synergistically as a molecular target in combination with cisplatin. , 2017, Urologic oncology.

[25]  Muhammad S. Khan,et al.  Landmarks in the treatment of muscle-invasive bladder cancer , 2017, Nature Reviews Urology.

[26]  Junying Yuan,et al.  Necroptosis and Cancer. , 2017, Trends in cancer.

[27]  Kiyotsugu Yoshida,et al.  Cell death decision by p53 via control of the mitochondrial membrane. , 2015, Cancer letters.

[28]  M. Knowles,et al.  Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity , 2014, Nature Reviews Cancer.

[29]  Qingqing Cai,et al.  linc-UBC1 physically associates with polycomb repressive complex 2 (PRC2) and acts as a negative prognostic factor for lymph node metastasis and survival in bladder cancer. , 2013, Biochimica et biophysica acta.

[30]  W. Curran,et al.  Pronecrotic mixed lineage kinase domain‐like protein expression is a prognostic biomarker in patients with early‐stage resected pancreatic adenocarcinoma , 2013, Cancer.

[31]  Xiaohui Lin,et al.  A support vector machine-recursive feature elimination feature selection method based on artificial contrast variables and mutual information. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[32]  Huanming Yang,et al.  Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder , 2011, Nature Genetics.

[33]  D. Silverman,et al.  Association between smoking and risk of bladder cancer among men and women. , 2011, JAMA.

[34]  Jiahuai Han,et al.  Nod1-dependent control of tumor growth. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[35]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.